Oncology
News
Sunscreen Found to Cut Melanoma Incidence
Major Finding: Patient randomly assigned to use sunscreen daily for 5 years had a lower incidence of melanoma during 10 further years of follow-up...
News
Imatinib Plus Bone Marrow Transplant Boost Survival in Ph+ ALL
Major Finding: The 3-year overall survival of Philadelphia chromosome–positive ALL improved from 25%, before imatinib was introduced, to 43% after...
News
Serrated Polyps Together With Adenomas Raise CRC Risk
Major Finding: Patients with both sessile serrated polyps and adenomas were significantly more likely to have large sessile serrated polyps (10 mm...
News
FLVCR Function New Target in Fight Against Malaria
News
Nilotinib Improves CML Outcomes at 3 Years
News
Scoring System Predicts Recurrent VTE Risk in Cancer Patients
Major Finding: Predictors for risk of recurrent venous thromboembolism (VTE) in cancer patients are lung cancer, female gender, and a prior VTE....
News
Brentuximab Induced Complete Remission in Refractory Hodgkin's Lymphoma
Major Finding: The investigational agent, brentuximab vedotin, was associated with complete remission in 34% of patients whose Hodgkin’s lymphoma...
News
Novel CML Drug Active After Failures of Imatinib, Dasatinib, and Nilotinib
Major Finding: Two-thirds of patients resistant to other tyrosine kinase inhibitors had a major cytogenetic response with ponatinib.Data Source: A...
News
Apixaban Tops Enoxaparin for VTE Prevention After Joint Replacement
News
Study Shows Rivaroxaban Valid for VTE Prophylaxis
Major Finding: Venous thromboembolism recurred in 2.1% of patients randomized to rivaroxaban and in 3.0% of patients randomized to enoxaparin...
News
Family Health History Beats Personal Genomic Screening for Cancer Risk
Major Finding: Of 22 individuals with a hereditary cancer risk, personal genomic screening identified only 1 as high risk.Data Source: Study of 22...